Find an expert

My research focuses on the engagement of stakeholders and the development of interventions to improve the health outcomes of cancer patients, Aboriginal and Torres Strait Islander people, and patients with chronic pain. These projects involved co-designing and delivering training programs for healthcare providers and consumers and assessing the clinical and public health outcomes.

I oversee the production and quality assurance of bioactive heparan sulfates (HS) used across various collaborative projects. In this role, I specialise in the selection and evaluation of pro-angiogenic HS through in vitro testing, their integration into biomaterials, and their subsequent assessment in preclinical animal models. My expertise encompasses a diverse range of skills, including biomaterial substrate fabrication (hydrogels, sponges, nano/micropatterned surfaces), structural and compositional characterisation, drug delivery systems, tissue processing (cell isolation, decellularisation, anastomosis), and cell-material interface analysis with a focus on signalling pathways (mechanotransduction and topographical cues). Collectively, I have contributed to multiple translational tissue engineering projects aimed at advancing regenerative medicine strategies for cardiovascular, dermal, bone and neural tissues. These multidisciplinary initiatives required close collaboration with program managers, scientists, and clinicians to ensure rigorous, high-quality research—from the in vitro characterisation of cellularised biomaterials to their successful implementation for in vivo studies.

We use computer based modelling techniques to understand and predict the the structural and dynamic properties of (bio)molecules including proteins and lipid aggregates.

Born in 1961, I obtained a BSc (Hon 1) at the University of Sydney in 1982. I obtained my PhD in 1986 from the John Curtin School of Medical Research, Australian National University (ANU), on the "Binding Responses Associated with Self-Interacting Ligands: Studies on the Self-Association and Receptor binding of Insulin”. After holding postdoctoral positions at the ANU, University of Groningen, The Netherlands and the Federal Institute of Technology (ETH), Zurich, Switzerland I was appointed Professor of Biophysical Chemistry (Molecular Simulation) University of Groningen, in 1998. In 1998 I also received the Swiss Ruzicka Prize for research in Chemistry for work on simulating peptide folding. In 2004 I was awarded an ARC Federation Fellowship and in February 2005 an honorary chair (Bijzonder Hoogleraar) at the University of Groningen, The Netherlands. I have given over 90 invited lectures at conferences and academic Institutions around the world as well as at a range of summer and winter schools on advanced simulation techniques.

In my research I have performed pioneering simulations of a variety of important biological phenomena, including some of the first atomic simulations of protein unfolding and the first simulations of reversible peptide folding in a realistic environment. In recent years my group performed some of the first atomic and near atomic simulations of the spontaneous aggregation of surfactant and lipid systems into micelles, bilayers and vesicles. These have enabled us, amongst other things, to elucidate the mechanism by which pores are induced within biological membranes in unprecedented detail. Over the last decade I have been intimately involved in the development of the GROMOS force field which is specifically tuned for protein and peptide folding simulations and as well as the development of models for a range of solvents including methanol and trifluoroethanol. I have also been responsible for the development of methodology for the calculations of the thermodynamic properties of biomolecular systems such as free energies of binding and hydration, as well as estimating entropic effects from simulations. Most recently, I have been responsible for the development of novel approaches to promote structure formation in protein folding simulations that can be used for the refinement of protein structures generated by ab initio or by homology methods. Finally, I am associated with two, internationally recognised, (bio)molecular simulation packages the GROningen Molecular Simulation library (GROMOS) and the GROningen Machine for Chemical Simulations (GROMACS).

Conserving biodiversity is essential for maintaining the health of the environment upon which human life and wellbeing relies. But the task will only get harder, with human pressures increasing in magnitude and ubiquity. My research tackles questions central to this challenge. A particular focus is biodiversity net gain policy, particularly the design and consequences of biodiversity offsetting, as well as the conservation and restoration of Australia’s woodlands and woodland bird assemblages. I collaborate with a broad network of individuals and organisations including government and non-government bodies to help achieve effective uptake of research findings into policy and environmental management. Sound conservation policy is essential if we are to apply ecological knowledge to reduce and ultimately halt biodiversity declines. I provide guidance on offset/no net loss/net gain policy development internationally including in Malaysia, the UK, Mozambique, and Guinea, and to intergovernmental convening bodies including IPBES, the UN Convention to Combat Desertification, the Convention on Biological Diversity, and the IUCN. I currently chair the IUCN’s Impact Mitigation and Ecological Compensation Thematic Group, am a director of BirdLife Australia and the Australian Wildlife Conservancy, and am a member of the Wentworth Group of Concerned Scientists and The Biodiversity Council. My research group is part of the Centre for Biodiversity & Conservation Science.

Dr Henry Marshall is a Thoracic Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre. Dr Marshall's research interests are in lung cancer screening/early detection and smoking cessation. His PhD (UQ 2015) was based on the first trial of lung cancer screening in Australia. He is site PI for Australia's second screening trial, the International Lung Screen Trial.

Dr. Helen Marshall is an acclaimed writer, editor and book historian. Her first collection of fiction, Hair Side, Flesh Side, takes its name from the two sides of a piece of parchment—animal skin scraped, stretched and prepared to hold writing. Gifts for the One Who Comes After, her second collection, borrows tropes from the Gothic tradition to negotiate issues of legacy and tradition. Collectively, her two books of short stories have won the World Fantasy Award, the British Fantasy Award, and the Shirley Jackson Award for outstanding achievement in the literature of psychological suspense, horror and the dark fantastic.

Her research as both as a creative practitioner and a scholar emerges out of the recent interest in “weird” fiction, a sub-genre of fantasy which blends supernatural, mythical, and scientific writing. Using modern theories of cognition, my work posits weird texts as “emotion machine[s]” (Tan 1996) designed to defamiliarize traumatic experiences so they can be more easily managed. Her debut novel The Migration (Random House Canada/Titan UK, 2019) exemplifies this. It finds parallels between the emergence of the Black Death in the fourteenth century and the ecological crises of the twenty-first century—that is, periods when humanity has had to confront the possibility of widescale loss of life. What interests her about the topic is not its bleakness but its interrogation of how change might take place, particularly for young people. The Migration explores these challenges. It initially presents metamorphosis as a major crisis, terrifying in its transfiguration of death. But, as the novel progresses, it shows the potential for hopeful and radical change.

Over the last five years notions of the apocalypse have emerged as a theme in her work. Her second collection, Gifts for the One Who Comes After addressed the shaping and persistence of memory in the wake of dangerous upheaval. Rather than taking the long view of history in my first collection, it negotiated very personal issues of legacy and tradition, creating myth-infused worlds where “love is as liable to cut as to cradle, childhood is a supernatural minefield, and death is ‘the slow undoing of beautiful things’” (Quill & Quire, starred review). Likewise her most recent edited collection The Year’s Best Weird Fiction argues that the techniques of defamiliarization used by contemporary authors such as Jeff VanderMeer and China Miéville offer routes for engaging in an increasingly destabilized world.

As a creative practitioner she has worked with interdisciplinary teams using narrative skills, worldbuilding and gamification for the UK’s Ministry of Defence (future threat prediction), the Diamantina Institute (storytelling and empathy for medical researchers), CERN, the European Organization for Nuclear Research (future technologies), and the Department of Defence (innovation and AI – funded $260,000). She has led international workshops to research how creative skills might be applied to wicked problems and she has led a project to apply these skills to technology foresight for the Defence Science Technology Group (Web 3.0 - funded $89,097).

She has further interests in both modern and medieval publishing cultures. Her PhD examined the codicology and palaeography of late medieval manuscripts from England, looking at how Middle English “bestsellers” such as Chaucer’s Canterbury Tales and the anonymous Prick of Conscience made use of traceable networks of production and dissemination. This work builds upon the practical experience she gained working in the publishing industry as the Managing Editor for ChiZine Publications, Canada’s largest independent genre press, where she was involved in all aspects of production including editing, marketing and business management. In 2016 she undertook a research project to investigate the publishing history of Stephen King’s Carrie (1974), which provided a snapshot of the changing social, economic and cultural environment of the publishing industry when key editorial and marketing decisions fashioned the King brand.

Her current projects explore worldbuilding, franchise writing, and the application of creative arts methodologies for interdisciplinary and transdisciplinary ideation.

Dr Jeanne Marshall is a speech pathologist with expertise in paediatric feeding and swallowing. She is currently employed in a conjoint role between Children's Health Queensland Hospital and Health Service and The University of Queensland. Jeanne’s primary research interest is paediatric feeding disorder, with a particular focus on preventative health in this area. Jeanne has various projects aligned with this concept, across the themes of better diagnostics, early intervention, and awareness and advocacy. Jeanne also has a passion for research translation and building research capacity in the health workforce, working alongside clinicians at Children's Health Queensland to improve care on the front line.

Work Profile: Dr Jeanne Marshall is a Conjoint Senior Research Fellow in speech pathology and an advanced speech pathologist at the Queensland Children's Hospital.

Teaching Themes: Paediatric dysphagia, research methodology, research translation

Research interests: Paediatric Feeding Disorder (PFD); paediatric dysphagia, paediatric trachestomy, complex medical infants and children

Publications: 44 peer-reviewed journal articles and 2 invited editorials. Impact: 412 citations, H-index = 12, average citations per paper = 14.2, field weighted citation impact = 1.61 (2024) (Scopus, May 2025).

Reviewer: International Journal of Speech-Language Pathology; Journal of Paediatrics and Child Health; American Journal of Speech-Language Pathology; Dysphagia; Nutrients

Editorial Boards: Associate Editor for Speech, Language and Hearing

Professional Memberships: Speech Pathology Australia; American Speech Hearing Association International Affiliate

I am Director of Centre for Policy Futures and Coordinator for the Queensland Decarbonisation Hub. Previously I was the Deputy Executive Dean of the Faculty of Humanities, Arts and Social Sciences, a former Head of School for the School of Social Science and Acting Associate Dean Research. My research interests include work and employment, poverty and economic security and the social dimensions of climate change. I am a Fellow of the Academy of the Social Sciences in Australia, and was a member of the ARC College of Experts from 2014-2016. Prior to entering academy I worked in the non-profit sector at the state, national and international level. I am the Australian representative for the Basic Income Earth Network.

Jenny Martin trained as a pharmacist at the Victorian College of Pharmacy (VCP), where she was awarded the Gold Medal for top student over the BPharm course. After completing an MPharm in computational chemistry at the College, Jenny moved to Oxford University for a PhD by research in protein crystallography and drug design. Her DPhil was supported by a prestigious 1851 Science Research Scholarship and several other competitive scholarships. Jenny then undertook two years of postdoctoral research at Rockefeller University in New York, before returning to Australia in 1993 to establish the first protein crystallography laboratory in Queensland. Since then, she has held ARC QEII, ARC Professorial and NHMRC Fellowships and is currently an ARC Australian Laureate Fellow at the Institute for Molecular Bioscience, University of Queensland. Jenny is the recipient of many honours including the ASBMB Roche Medal, the Queensland Smart Women Smart State Research Scientist award, and the Women in Biotech Outstanding Outstanding Biotechnology Achievement Award.

I am a sport scientist with a background in exercise physiology who has focused on applying cutting-edge science and technology to improve human performance, healthspan, and high-performance systems. My work bridges elite sport, health span, and application of sport technology.

With over 30 years of experience across Olympic sport, professional teams, and health technology startups, I specialise in designing high-performance environments that integrate science, coaching, and technology to drive measurable results.

Core expertise and keywords:

• High-performance sport and human performance

• Sport science and exercise physiology

• Wearable technology and data analytics

• Healthspan optimization and longevity

• Talent identification and performance systems

• Innovation strategy and multidisciplinary teams

I currently hold a conjoint role with the University of Queensland and the Queensland Academy of Sport where I am the Head of the Research and Innovation Unit. Prior to arriving at the University of Queensland, I worked as the Chief Scientist and Director of Performance for a Silicon Valley performance health science start-up company.

Previously, I held leadership roles with the Philadelphia 76ers (Director of Performance) and the Australian Institute of Sport (Senior Sport Scientist), supporting Olympic and professional athletes through applied research, technology integration, and high-performance team design.

My work connects research with real-world impact, supporting athletes, executives, and organizations seeking a competitive edge through science-driven performance and health innovation.

I am a clinician researcher with experience in health services research, transdisciplinary care, stroke research, implementation science, and consumer engagement. I am passionate about optimising healthcare services and improving patient care by identifying and addressing inefficiencies using innovative models of care and solutions. I am an expert in the field of transdisciplinary healthcare models.

I am also an occupational therapist with over 8 years of experience in direct patient care across multiple hospital settings, including acute stroke, neuroscience, general medical, orthopaedics, and surgical. I currently work as a Service Improvement and Innovation Officer for community healthcare services at Mater at Home.